For individuals who discontinued treatment, weight and cardiometabolic risk factors were assumed to revert to baseline levels within a year, followed by risk factorspecific temporal trends in subsequent years
Wegovy (semaglutide 2.4 mg) slows gastric emptying and can cause gastrointestinal side effects such as nausea and indigestion, leading to understandable concerns about food choices
Data was weighted to be nationally representative across age, gender, region, race, and ethnicity (using the latest publicly available US Ccnsus numbers)
What the Sign-Up and Approval Process Is Actually Like The sign-up process with Fifty 410 is straightforward, and simple to fill out
All content is fact-checked for accuracy, timeliness and relevance